OncoSil Medical Secures TGA Approval in Australia for Pancreatic Cancer Device

OncoSil Medical wins TGA approval for OncoSil device to treat unresectable LAPC; ARTG-listed, enabling Australian launch as manufacturing scales up.

Read on WOBR AI →